How To Submit An Abstract

The abstract submitter must meet the following requirements:

• Be an oncology/hematology advanced practitioner (AP): NP, PA, PharmD, CNS, or
  master’s degree or higher advanced practice nurse,
• Complete all requirements of abstract submission, and
•  Attend the conference, including the moderated poster sessions, to present the poster
  should the abstract be accepted.

Abstract Submission Categories

• Advanced Practice Initiatives (such as AP-Led Practice Initiatives, Educational
  Initiatives, and Leadership/Professional Growth)
•  AP-Led Quality Improvement (such as Quality of Care)
• AP-Led Clinical Research
• Additionally, abstracts will be considered in the following categories:
  
  • • Precision oncology
    • Targeted therapy
    • Early phase and targeted trial design
    • Translational studies
    • Biomarker and translational studies
    • Drug discovery and design

Type of Poster:

• Research & Clinical Posters: Research & Clinical posters focus on research,
  clinical/evidence-based practice guidelines, medical interventions, novel therapies,
  patient outcomes, diagnostic methods, public health, and case studies.
•  Clinical Trials in Progress: Clinical Trials in Progress posters highlight ongoing clinical
  trials, including the study design, treatment arms, eligibility criteria, current enrollment
  status, and the rationale behind the research.
• Encore Posters: Encore Posters are defined as posters previously presented at a
  national or international hematology/oncology conference but contain information of
  interest and importance to clinicians managing patients with cancer. Encore posters must
  have been presented within 16 months of the STOP Cancer abstract submission deadline
  (June 13, 2024). Encore posters may be submitted and presented, if accepted, by an
  author on the original abstract or an industry representative with permission. A fee of
  $2,500 per poster applies, if accepted.

Submitting Online
All abstracts must be submitted via the online submission form located HERE

• Complete all sections of the application. If planning to submit more than one poster for consideration, you must submit a separate application for each one.
• Abstracts can only be submitted electronically.
• Abstracts must be 250 words or less and include a purpose statement.
• Submissions will be peer-reviewed by a selection committee for quality and relevance.
• Posters may be no larger than 36 inches by 48 inches in size.
• Poster templates can be found HERE, or you are welcome to create your own.

Submission Deadline

Abstracts will be accepted from April 1, 2025 until 11:59 PM ET, June 13th, 2025

Acceptance Notification
Decision notifications will be emailed to the primary presenter by July 13th, 2025

Additional Considerations
Presenting a poster at the ACRS is a voluntary effort and Horizon CME cannot pay expenses for your participation. If your submission is accepted, you are responsible for your own meeting registration fee and travel expenses. All presenters must be registered for the meeting, at least for the day of your poster presentation.

A $2,500 fee will be charged for poster submissions accepted from Industry.

All questions should be directed to Rachael M. Andrie, PhD, Senior Associate Medical Director, at:

rachael.andrie@horizoncme.com